Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Current Deferred Revenue: 2018-2025

Historic Current Deferred Revenue for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Mar 2025 value amounting to $58,627.

  • China SXT Pharmaceuticals' Current Deferred Revenue rose 295.81% to $5,240 in Q3 2025 from the same period last year, while for Sep 2025 it was $5,240, marking a year-over-year increase of 295.81%. This contributed to the annual value of $58,627 for FY2025, which is 68.76% down from last year.
  • Latest data reveals that China SXT Pharmaceuticals reported Current Deferred Revenue of $58,627 as of FY2025, which was down 68.76% from $187,665 recorded in FY2024.
  • China SXT Pharmaceuticals' 5-year Current Deferred Revenue high stood at $257,449 for FY2021, and its period low was $58,627 during FY2025.
  • For the 3-year period, China SXT Pharmaceuticals' Current Deferred Revenue averaged around $137,275, with its median value being $165,534 (2023).
  • Per our database at Business Quant, China SXT Pharmaceuticals' Current Deferred Revenue slumped by 69.95% in 2022 and then spiked by 113.96% in 2023.
  • Yearly analysis of 5 years shows China SXT Pharmaceuticals' Current Deferred Revenue stood at $257,449 in 2021, then slumped by 69.95% to $77,366 in 2022, then surged by 113.96% to $165,534 in 2023, then rose by 13.37% to $187,665 in 2024, then crashed by 68.76% to $58,627 in 2025.